|
NUS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
9.87930000000414E-05 |
| Normal-vs-Stage3 |
5.036300E-04 |
| Normal-vs-Stage4 |
4.598600E-03 |
| Stage1-vs-Stage2 |
3.617600E-01 |
| Stage1-vs-Stage3 |
8.827900E-02 |
| Stage1-vs-Stage4 |
3.022200E-01 |
| Stage2-vs-Stage3 |
6.294600E-01 |
| Stage2-vs-Stage4 |
7.450800E-01 |
| Stage3-vs-Stage4 |
9.212400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
8.86639983654902E-10 |
| Normal-vs-Asian |
4.541800E-02 |
| Caucasian-vs-AfricanAmerican |
4.316400E-01 |
| Caucasian-vs-Asian |
9.184200E-01 |
| AfricanAmerican-vs-Asian |
7.179400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.20619999993887E-07 |
| Male-vs-Female |
1.238530E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.98060004350265E-09 |
| Normal-vs-Extreme_Weight |
1.11022302462516E-16 |
| Normal-vs-Obese |
1.19659999686661E-08 |
| Normal-vs-Extreme_Obese |
4.542900E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.557550E-01 |
| Normal_Weight-vs-Obese |
4.874600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.592600E-01 |
| Extreme_Weight-vs-Obese |
1.863790E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.336200E-01 |
| Obese-vs-Extreme_Obese |
5.695200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.429580E-02 |
| Normal-vs-Age(41-60Yrs) |
5.01598762525646E-13 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.80700027058367E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.965600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.006390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.041010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.492400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.155820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.164000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
6.65745236716475E-12 |
| Normal-VS-KIRP CIMP |
3.301200E-01 |
| Normal-VS-Unclassified PRCC |
1.66420000002887E-08 |
| Type1 PRCC-VS-Type2 PRCC |
8.738400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.467950E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.038200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.533700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.333800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.183700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62503344114384E-12 |
| Normal-vs-N1 |
4.238300E-02 |
| Normal-vs-N2 |
1.01419999998242E-06 |
| N0-vs-N1 |
5.724200E-03 |
| N0-vs-N2 |
8.377600E-01 |
| N1-vs-N2 |
1.718550E-01 |
|
|
